MedPath

Intrathecal hyperbaric bupivacaine versus hyperbaric ropivacaine in spinal anaesthesia in caesarean sections: a randomised control trial in a teaching hospital in northeast India.

Phase 3
Conditions
Health Condition 1: O298- Other complications of anesthesiaduring pregnancy
Registration Number
CTRI/2024/05/067399
Lead Sponsor
eon
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

i.All patients who will be registered for elective caesarean delivery and belonging to ASA (American Society of Anesthesiologists) grade I & II only.

ii.Patients between 145to 165 cms of height.

iii.Patients who will give valid informed written consent.

iv.Pregnancy over 37 weeks and less than 42 weeks.

v.Patient with weight of 45-95kgs.

vi.Patients with age between 18years and 40 years.

Exclusion Criteria

i.Patient with abnormalities and problems in the embryo.

ii.Patient with indication of an emergency caesarean section.

iii.Patients having history of hypersensitivity to anesthetic agents.

iv.Infection at the subarachnoid block injection site.

v.Pre-term and post term delivery.

vi.ASA class higher than II.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath